13F

Stock

Iovance Biotherapeutics, Inc.

IOVA · held by 2 managers

Reported value

$3.8M

Holders

2

+0 new · −0 exited

Holders’ est. mark

$390.1K

Price effect on 2 books still in the name

Largest holder

$3.73M

BARCLAYS PLC

Holder count by quarter

Who holds it

Notable only
InvestorSharesValueEst. markChange
BARCLAYS PLC529.6K$3.73M$388KAdded$1.18M
Leonteq Securities AG10.8K$76.1K$2.17KAdded$61.8K

Positions as of Q2 2023. 13F filings arrive up to 45 days after quarter-end and omit shorts. Values are quarter-end marks, as filed. Estimated mark is the price effect on shares still held — not realized P&L or investment advice.